Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02761330 · ClinicalTrials.gov registry record · NA
Cognitive Recovery After Electroconvulsive Therapy and General Anesthesia
A NA study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 17
- Enrollment target
NCT02761330 is a NA study that has completed, run by Washington University School of Medicine. The registered enrollment target is 17 participants.
The verdict
NCT02761330, a NA study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
Study Summary
This study is geared toward characterizing the recovery of brain activity and cognitive function following treatments of electroconvulsive therapy and ketamine general anesthesia.
Interventions
- DRUG Ketamine
- PROCEDURE Electroconvulsive Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2016-04 |
| Est. Completion | 2019-09-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02761330
The ClinicalTrials.gov registry entry for NCT02761330 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ketamine is the first listed.
NCT02761330 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02761330 about?
NCT02761330 is a clinical study titled "Cognitive Recovery After Electroconvulsive Therapy and General Anesthesia". This study is geared toward characterizing the recovery of brain activity and cognitive function following treatments of electroconvulsive therapy and ketamine general anesthesia.
What is the current status of trial NCT02761330?
This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2016-04. Estimated completion is 2019-09-11.
What interventions are being tested in trial NCT02761330?
The interventions under investigation include: Ketamine (DRUG), Electroconvulsive Therapy (PROCEDURE).
Who is sponsoring clinical trial NCT02761330?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.